- +1-315-215-1633
- sales@thebrainyinsights.com
The global anti-inflammatory drugs market is expected to grow from USD 95.23 billion in 2022 to USD 164.97 billion by 2030, at a CAGR of 7.11% during the forecast period 2022-2030. The North American region anti-inflammatory drugs market share is 39.88% in 2022.
Inflammation is the swelling up of a wound or an injury. Inflammation is accompanied by swelling, redness, irritation, and pain. Inflammation is the body's immune response to a foreign irritants like germs, toxins, pollution, and chemicals. Anti-inflammatory drugs are therapeutic drugs that reduce inflammation. They reduce the body part's swelling and offer the patient relief and comfort. Non-steroidal anti-inflammatory drugs are the most common and known therapeutics for treating inflammation. Some anti-inflammatory drugs include Ibuprofen, naproxen, celecoxib, indomethacin, and celecoxib. Anti-inflammatory drugs are also prescribed to reduce fever, headaches, and body pain. They are also a medication for sprains, strains, colds, flu, and arthritis. They are also effective in reducing menstrual pain. Anti-inflammatory drugs are used to treat long-term pain as well. The increasing prevalence of acute diseases such as cold and flu and chronic conditions such as arthritis will propel the market's growth. New drugs that are efficient in treating inflammation have been discovered due to developments in the medical field. Anti-inflammatory medicine demand is expected to increase as people become more aware of their benefits. The growing accessibility of the drugs will also facilitate the market's growth.
Get an overview of this study by requesting a free sample
January 2022 – CIBINQO, an oral Janus kinase 1 (JAK1) inhibitor, was approved by the U.S. Food and Drug Administration (FDA). The drug was approved for treating adults with refractory, moderate-to-severe atopic dermatitis (AD), whose condition is not adequately controlled by other systemic drug products, including biologics, or when using other therapies is not recommended.
December 2021 - Arena Pharmaceuticals, Inc., which is in the trial stages of researching novel potential treatments for many immuno-inflammatory illnesses, and Pfizer Inc. entered into a binding agreement. Following the agreement, Pfizer bought all of Arena's outstanding shares for USD 100 in an all-cash deal, giving Arena a total stock value of almost USD 6.7 billion. The deal was endorsed by both boards of directors in unanimity. Etrasimod is a selective sphingosine receptor modulator developed for immuno-inflammatory diseases. Arena's portfolio includes a variety of promising therapeutic candidates in gastroenterology, dermatology, and cardiology.
Drivers:
According to the World Health Organization, the increasing geriatric population is around 1 billion people aged 60 and above. The number is expected to reach 2 billion or double by 2050. The tendons of the body become less elastic with age and are prone to injury. Furthermore, moderate chronic pain at an early age becomes severe chronic pain if not treated properly. As the bone loses density and mass, it becomes more vulnerable to injury. The systemic inflammation progresses with age, and the pain is more severe. The pain also persists over a long duration. The prevalence of diabetes is also a significant contributing factor to the increased inflammation in elderlies. The increasing number of cancer patients also contributes to the growing demand for anti-inflammatory drugs. Therefore, the rising geriatric population will drive the global anti-inflammatory drugs market. The increasing accessibility to medication is a complementary development benefiting the market.
Restraints:
Increasing awareness about the potential side effects of the drugs – Every drug has several possible side effects that vary in severity. The widespread use of anti-inflammatory drugs has prompted scientists globally to understand their potential side effects on patients. The increasing research has presented extensive evidence connecting NSAIDs to the rising risk of cardiovascular conditions. The conditions can be heart attacks, heart failure, heart stroke, and atrial fibrillation. The increasing awareness about the potential side effects of anti-inflammatory drugs will reduce the demand for the drugs in the market, given the rising concerns about their consumption. Therefore, this could limit the growth of the market.
Opportunities:
Research and development in the market – The increasing awareness about anti-inflammatory drugs has increased their demand. The major players in the market are perpetually involved in the research and development of new drugs to exploit the massive consumer market of anti-inflammatory drugs. The extensive portfolio and their easy accessibility are also aiding the market's growth. For instance, the development of anti-inflammatory biologics that have lesser side effects on the body and are more effective in treating pain is ushering in a new market development era. The comprehensive approval mechanisms have been streamlined to fast-track drug approvals, encourage innovation in the market and improve industry compliance. The standardized regulations of the government are also facilitating better product innovations in the market. Therefore, enhanced research and development will offer lucrative opportunities for the market.
Challenges:
Concerns about patent expiry - The pharmaceutical giants spend millions on research and development of new drugs, therapies, and treatments that could potentially cure a condition or disease. A company's extensive research and development are only carried out when they are guaranteed an exclusive right to manufacture, produce and distribute its drug in the public domain. The patents awarded by regulators guarantee that the pharmaceutical giants can reap the benefits of their discovery and recover the money they put into developing the drugs and profits. However, the patents are awarded for a specific time, and the expiration of a patent opens up the opportunity for other market players to reverse engineer and sell the same drug without any significant expenditure. Poor patent laws and inadequate implementation discourage innovation and could challenge the market's growth.
Regional segmentation analysis:
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest market for the global anti-inflammatory drugs market, with a 39.88% market revenue share in 2022. The development of effective and promising anti-inflammatory medications in the regional market, given the presence of major industry players, contributes to the region's dominance. The North American market will be driven by the rising private capital investment in the research & development of new drugs to address the expanding demand for anti-inflammatory medications. Government initiatives supporting the pharmaceutical industry's growth will also benefit the market for anti-inflammatory medications. The well-established healthcare system makes treatments accessible and inexpensive for the populace, which supports market growth. Due to the government's increased spending on the healthcare industry due to the pandemic, the Asia Pacific market is anticipated to grow over the projected period. Major participants in the market for anti-inflammatory medications will be drawn to the region due to the expansion of the healthcare infrastructure and the region's sizable population, propelling its growth over the projected period.
North America Region Anti-Inflammatory Drugs Market Share in 2022 - 39.88%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Product type segment analysis
The product type segment is divided into anti-inflammatory biologics, corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs). The non-steroidal anti-inflammatory drugs (NSAIDs) segment dominated the market with a revenue share of around 68% in 2022. Non-steroidal anti-inflammatory drugs are the therapeutics primarily used to reduce inflammation, fever, and pain and prevent blood clots. Aspirin, ibuprofen, naproxen and celecoxib are some NSAIDs. NSAIDs are highly popular in the market among the general public. They are a preferred over-the-counter drug class used to reduce fever, pain, and inflammation by a significant proportion of the population. The extensive advertising campaigns portraying NSAIDs as effective pain-reducing drugs used for headaches, migraine, and menstrual pain also facilitates the segment's growth. The accessibility of drugs has increased, given that it is sold at every pharmacy or drug store, and will also aid the segment's growth.
Disease type segment analysis
The disease type segment is divided into autoimmune inflammatory diseases, respiratory diseases, anti-inflammatory bowel diseases, and others. Over the forecast period, the autoimmune inflammatory diseases segment is expected to grow at the fastest CAGR of 9.24%. Autoimmune anti-inflammatory diseases are when the body's immune system attacks its healthy cells. The body becomes incapable of distinguishing between healthy and non-healthy cells. The increasing prevalence of autoimmune inflammatory diseases like rheumatoid arthritis, lupus, multiple sclerosis, and polymyalgia rheumatic will contribute to the segment's growth. The increasing exposure to multiple infections, toxins, and medications contributes to the increasing number of autoimmune inflammatory diseases. The increasing prevalence of obesity and smoking will also increase the number of patients and propel market growth.
Route of administration segment analysis
The route of administration segment is divided into oral, topical, inhalation, injection, and parenteral. The oral segment dominated the market with a market share of around 56% in 2022. Oral medications are the preferred choice of consumers, given their convenience. They are the simplest form of drugs, making them easy to manufacture on a large scale. They can be self-administered and are ideal for prolonged and repeated use. The safety of the oral route of administration makes it the preferred method in the market. The absence of sterile precautions and the economical nature of the oral route of administration contribute to its dominance in the market.
Distribution channel segment analysis
The distribution channel segment is divided into hospital pharmacies, online pharmacies, retail pharmacies, and others. The retail pharmacies segment dominated the market with a market share of around 54% in 2022. The increasing number of supermarket pharmacies facilitates the expansion of the industry. Anti-inflammatory drugs mostly don't require a prescription and are widely available as over-the-counter drugs in pharmacies, which increases the demand for retail pharmacies. Retail pharmacies' accessibility has a big impact on the segment's growth.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 95.23 Billion |
| Market size value in 2030 | USD 164.97 Billion |
| CAGR (2022 to 2030) | 7.11% |
| Historical data | 2019-2020 |
| Base Year | 2021 |
| Forecast | 2022-2030 |
| Segments | The research segment is based on product type, disease type, route of administration, and distribution channel. |
| Regional Segments | The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. |
As per The Brainy Insights, the size of the anti-inflammatory drugs market was valued at USD 95.23 billion in 2022 to USD 164.97 billion by 2030.
Global anti-inflammatory drugs market is growing at a CAGR of 7.11% during the forecast period 2022-2030.
The market's growth will be influenced by the increasing geriatric population.
Increasing awareness about the potential side-effects of the drugs could hamper the market growth.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product Type
4.3.2. Market Attractiveness Analysis by Disease Type
4.3.3. Market Attractiveness Analysis by Route of Administration
4.3.4. Market Attractiveness Analysis by Distribution Channel
4.3.5. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The increasing geriatric population
5.3. Restraints
5.3.1. Increasing awareness about the potential side-effects of the drugs
5.4. Opportunities
5.4.1. Research and development in the market
5.5. Challenges
5.5.1. Concerns about patent expiry
6. Global Anti-Inflammatory Drugs Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Anti-Inflammatory Biologics
6.3. Corticosteroids
6.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
7. Global Anti-Inflammatory Drugs Market Analysis and Forecast, By Disease Type
7.1. Segment Overview
7.2. Autoimmune Inflammatory Diseases
7.3. Respiratory Diseases
7.4. Anti-Inflammatory Bowel Diseases
7.5. Others
8. Global Anti-Inflammatory Drugs Market Analysis and Forecast, By Route of Administration
8.1. Segment Overview
8.2. Oral
8.3. Topical
8.4. Inhalation
8.5. Injection
8.6. Parenteral
9. Global Anti-Inflammatory Drugs Market Analysis and Forecast, By Distribution Channel
9.1. Segment Overview
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
9.5. Others
10. Global Anti-Inflammatory Drugs Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.5. South America
10.5.1. Brazil
10.6. Middle East and Africa
10.6.1. UAE
10.6.2. South Africa
11. Global Anti-Inflammatory Drugs Market-Competitive Landscape
11.1. Overview
11.2. Market Share of Key Players in the Anti-Inflammatory Drugs Market
11.2.1. Global Company Market Share
11.2.2. North America Company Market Share
11.2.3. Europe Company Market Share
11.2.4. APAC Company Market Share
11.3. Competitive Situations and Trends
11.3.1. Product Launches and Developments
11.3.2. Partnerships, Collaborations, and Agreements
11.3.3. Mergers & Acquisitions
11.3.4. Expansions
12. Company Profiles
12.1. AbbVie Inc.
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Product Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Johnson & Johnson Services Inc.
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Product Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Eli Lily and Company
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Product Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. AstraZeneca Plc
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Product Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. Hoffmann-La Roche AG
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Product Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. Amgen Inc.
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Product Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. Bristol-Myers Squibb
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Product Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. GlaxoSmithKline
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Product Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Novartis Pharmaceuticals Corporation
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Product Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
12.10. Pfizer
12.10.1. Business Overview
12.10.2. Company Snapshot
12.10.3. Company Market Share Analysis
12.10.4. Company Product Portfolio
12.10.5. Recent Developments
12.10.6. SWOT Analysis
List of Table
1. Global Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
2. Global Anti-Inflammatory Biologics Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
3. Global Corticosteroids Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
5. Global Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
6. Global Autoimmune Inflammatory Diseases Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
7. Global Respiratory Diseases Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
8. Global Anti-Inflammatory Bowel Diseases Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
9. Global Others Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
10. Global Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
11. Global Oral Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
12. Global Topical Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
13. Global Inhalation Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
14. Global Injection Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
15. Global Parenteral Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
16. Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
17. Global Hospital Pharmacies Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
18. Global Online Pharmacies Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
19. Global Retail Pharmacies Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
20. Global Others Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
21. Global Anti-Inflammatory Drugs Market, By Region, 2019-2030 (USD Billion)
22. North America Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
23. North America Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
24. North America Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
25. North America Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
26. U.S. Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
27. U.S. Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
28. U.S. Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
29. U.S. Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
30. Canada Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
31. Canada Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
32. Canada Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
33. Canada Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
34. Mexico Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
35. Mexico Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
36. Mexico Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
37. Mexico Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
38. Europe Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
39. Europe Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
40. Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
41. Europe Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
42. Germany Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
43. Germany Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
44. Germany Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
45. Germany Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
46. France Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
47. France Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
48. France Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
49. France Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
50. U.K. Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
51. U.K. Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
52. U.K. Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
53. U.K. Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
54. Italy Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
55. Italy Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
56. Italy Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
57. Italy Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
58. Spain Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
59. Spain Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
60. Spain Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
61. Spain Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
62. Asia Pacific Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
63. Asia Pacific Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
64. Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
65. Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
66. Japan Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
67. Japan Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
68. Japan Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
69. Japan Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
70. China Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
71. China Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
72. China Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
73. China Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
74. India Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
75. India Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
76. India Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
77. India Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
78. South America Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
79. South America Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
80. South America Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
81. South America Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
82. Brazil Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
83. Brazil Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
84. Brazil Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
85. Brazil Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
86. Middle East and Africa Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
87. Middle East and Africa Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
88. Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
89. Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
90. UAE Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
91. UAE Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
92. UAE Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
93. UAE Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
94. South Africa Anti-Inflammatory Drugs Market, By Product Type, 2019-2030 (USD Billion)
95. South Africa Anti-Inflammatory Drugs Market, By Disease Type, 2019-2030 (USD Billion)
96. South Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2019-2030 (USD Billion)
97. South Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2019-2030 (USD Billion)
List of Figures
1. Global Anti-Inflammatory Drugs Market Segmentation
2. Anti-Inflammatory Drugs Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Anti-Inflammatory Drugs Market Attractiveness Analysis by Product Type
9. Global Anti-Inflammatory Drugs Market Attractiveness Analysis by Disease Type
10. Global Anti-Inflammatory Drugs Market Attractiveness Analysis by Route of Administration
11. Global Anti-Inflammatory Drugs Market Attractiveness Analysis by Distribution Channel
12. Global Anti-Inflammatory Drugs Market Attractiveness Analysis by Region
13. Global Anti-Inflammatory Drugs Market: Dynamics
14. Global Anti-Inflammatory Drugs Market Share by Product Type (2022 & 2030)
15. Global Anti-Inflammatory Drugs Market Share by Disease Type (2022 & 2030)
16. Global Anti-Inflammatory Drugs Market Share by Route of Administration (2022 & 2030)
17. Global Anti-Inflammatory Drugs Market Share by Distribution Channel (2022 & 2030)
18. Global Anti-Inflammatory Drugs Market Share by Regions (2022 & 2030)
19. Global Anti-Inflammatory Drugs Market Share by Company (2021)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the anti-inflammatory drugs market based on below mentioned segments:
Anti-Inflammatory Drugs Market by Product Type:
Anti-Inflammatory Drugs Market by Disease Type:
Anti-Inflammatory Drugs Market by Route of Administration:
Anti-Inflammatory Drugs Market by Distribution Channel:
Anti-Inflammatory Drugs Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
